VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

The company’s shares closed yesterday at $10.27. Harrison covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Apellis Pharmaceuticals, and Disc Medicine. According to ...

Evercore ISI analyst Liisa Bayko maintained a Hold rating on Theravance Biopharma (TBPH – Research Report) today and set a price target ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The American Association of Pharmaceutical Scientists (AAPS) is gearing up to be a groundbreaking conference and trade show AAPS PharmSci 360 2024. It is scheduled for October 20-23, 2024 at the ...